A staff of Genkyotex transfers cells with a multi-channel pipette before a measurement at the company...
Audrey Guerardel, a staff of Biotech company Genkyotex, transfers cells with a multi-channel pipette before doing a measurement at the company headquarters in Plan-les-Ouates in Geneva July 26, 2013. While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning. Picture taken July 26, 2013. To match story BIOTECH-EUROPE/FUNDING REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS SCIENCE TECHNOLOGY)